Top Markets
Coin of the day
Kazia Therapeutics Limited Kazia Therapeutics Limited

Kazia Therapeutics Limited

KZA
Rang in Aktien #35840
Kazia Therapeutics Limited is a biotechnology firm specializing in oncology,... Kazia Therapeutics Limited is a biotechnology firm specializing in oncology, committed to developing innovative therapies for cancer. Its flagship product candidate, Paxalisib, is a brain-penetrant small molecule that inhibits the PI3K/Akt/mTor pathway and is currently being investigated as a potential treatment for glioblastoma. Additionally, the company is progressing EVT801, an investigational new drug aimed at combating various types of cancer. Established in 1994 and headquartered in Sydney, Australia, the entity was formerly known as Novogen Limited before adopting the name Kazia Therapeutics Limited in November 2017.
Aktienkurs
$0.05207079
Zuletzt synchronisiert: 2023-11-15
Marktkapitalisierung
$3.38M
Veränderung (1 Tag)
0.13%
Veränderung (1 Jahr)
0.00%
Land
AU
Handel Kazia Therapeutics Limited (KZA)

Kategorie

Kursverlauf für Kazia Therapeutics Limited (KZA)
Höchster Schlusskurs: $0.05 am 2023-11-01

Niedrigster Schlusskurs: $2.34 am 1994-09-01
Kursverlauf der Aktie von Kazia Therapeutics Limited von 1994 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2023 -14.41%
2022 -93.21%
2021 -12.26%
2020 134.56%
2019 60.49%
2018 -10.55%
2017 -54.36%
2016 -26.11%
2015 4.87%
2014 -53.60%
2013 40.89%
2012 29.78%
2011 -12.03%
2010 -76.36%
2009 -1.22%
2008 -56.70%
2007 -44.36%
2006 -47.25%
2005 -15.26%
2004 -19.24%
2003 269.42%
2002 32.67%
2001 -37.00%
2000 -7.16%
1999 14.60%
1998 11.28%
1997 0.36%
1996 133.15%
1995 54.37%
1994 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE